Neuronetics Stock Total Asset
| STIM Stock | USD 3.81 0.31 8.86% |
Neuronetics fundamentals help investors to digest information that contributes to Neuronetics' financial success or failures. It also enables traders to predict the movement of Neuronetics Stock. The fundamental analysis module provides a way to measure Neuronetics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Neuronetics stock.
| Last Reported | Projected for Next Year | ||
| Total Assets | 115.8 M | 100.9 M | |
| Intangibles To Total Assets | 0.04 | 0.04 |
Neuronetics | Total Asset |
Neuronetics Company Total Asset Analysis
Neuronetics' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Neuronetics Total Asset | 115.83 M |
Most of Neuronetics' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neuronetics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Neuronetics Total Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Neuronetics is extremely important. It helps to project a fair market value of Neuronetics Stock properly, considering its historical fundamentals such as Total Asset. Since Neuronetics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Neuronetics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Neuronetics' interrelated accounts and indicators.
Click cells to compare fundamentals
Neuronetics Total Asset Historical Pattern
Today, most investors in Neuronetics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Neuronetics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Neuronetics total asset as a starting point in their analysis.
Neuronetics Total Asset |
| Timeline |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Neuronetics Total Assets
Total Assets |
|
Based on the latest financial disclosure, Neuronetics has a Total Asset of 115.83 M. This is 98.46% lower than that of the Health Care Equipment & Supplies sector and 96.28% lower than that of the Health Care industry. The total asset for all United States stocks is 99.61% higher than that of the company.
Neuronetics Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Neuronetics' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Neuronetics could also be used in its relative valuation, which is a method of valuing Neuronetics by comparing valuation metrics of similar companies.Neuronetics is currently under evaluation in total asset category among related companies.
Neuronetics Institutional Holders
Institutional Holdings refers to the ownership stake in Neuronetics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Neuronetics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Neuronetics' value.| Shares | Acadian Asset Management Llc | 2023-12-31 | 298.5 K | Geode Capital Management, Llc | 2023-12-31 | 265.6 K | Tang Capital Management Llc | 2023-09-30 | 200 K | Citadel Advisors Llc | 2023-09-30 | 192.6 K | Thompson, Siegel & Walmsley Llc | 2023-12-31 | 187.9 K | Hightower Advisors, Llc | 2023-12-31 | 183.2 K | Renaissance Technologies Corp | 2023-12-31 | 169 K | Marshall Wace Asset Management Ltd | 2023-12-31 | 143.3 K | Dimensional Fund Advisors, Inc. | 2023-12-31 | 114.7 K | Cannell Capital Llc | 2023-12-31 | 2.8 M | Archon Capital Management Llc | 2023-12-31 | 2.5 M |
Neuronetics Fundamentals
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (0.42) % | ||||
| Operating Margin | (0.12) % | ||||
| Current Valuation | 106.94 M | ||||
| Shares Outstanding | 29.97 M | ||||
| Shares Owned By Insiders | 6.31 % | ||||
| Shares Owned By Institutions | 65.13 % | ||||
| Number Of Shares Shorted | 57.69 K | ||||
| Price To Book | 3.76 X | ||||
| Price To Sales | 1.80 X | ||||
| Revenue | 71.35 M | ||||
| Gross Profit | 49.72 M | ||||
| EBITDA | (28.55 M) | ||||
| Net Income | (30.19 M) | ||||
| Cash And Equivalents | 73.7 M | ||||
| Cash Per Share | 2.71 X | ||||
| Total Debt | 62.47 M | ||||
| Debt To Equity | 0.63 % | ||||
| Current Ratio | 4.02 X | ||||
| Book Value Per Share | 1.18 X | ||||
| Cash Flow From Operations | (32.04 M) | ||||
| Short Ratio | 0.30 X | ||||
| Earnings Per Share | (1.05) X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 203 | ||||
| Beta | 2.44 | ||||
| Market Capitalization | 104.91 M | ||||
| Total Asset | 115.83 M | ||||
| Retained Earnings | (376.08 M) | ||||
| Working Capital | 73.98 M | ||||
| Net Asset | 115.83 M |
About Neuronetics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Neuronetics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neuronetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neuronetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| LAAC | Lithium Americas Corp | |
| F | Ford Motor | |
| CHPT | ChargePoint Holdings | |
| AXL | American Axle Manufacturing | |
| ICLN | iShares Global Clean |
Check out Neuronetics Piotroski F Score and Neuronetics Altman Z Score analysis. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Neuronetics Stock analysis
When running Neuronetics' price analysis, check to measure Neuronetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuronetics is operating at the current time. Most of Neuronetics' value examination focuses on studying past and present price action to predict the probability of Neuronetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuronetics' price. Additionally, you may evaluate how the addition of Neuronetics to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Neuronetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.05) | Revenue Per Share 2.49 | Quarterly Revenue Growth 0.116 | Return On Assets (0.15) | Return On Equity (0.66) |
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.